Peptilogics Receives Qualified Infectious Disease Product Designation from FDA for Lead Compound PLG0206 as a Treatment for Prosthetic Joint Infection by Morgane De Pol | Jun 7, 2018
CARB-X Funding Award to Advance Development of LpxC Inhibitor Antibiotic to Fight Drug Resistant by mcwebmaster | Dec 19, 2017
GSK – Public-Private Partnerships to Share Knowledge and Expertise in R&D by mcwebmaster | Dec 15, 2017
